Hx > Dx > Rx

Home | Contact Us | Site Map | PharmaNexus News Blog


Rx: Reasons for Choosing PNx for your Healthcare Communications Needs

Experience: Project Areas | Therapeutic Areas | Audiences | Results

PeerView Press

Best recent example is work done for PeerView Press, particularly the inSession reports which are listed below:

Go to www.peerviewpress.com

  • Close out the presentation in the top left window and close any subsequent underlying text window.
  • Select July 2004.
  • Select Search.
  • In the window on the right side of the screen select any of the four inSession CME programs from EULAR:
46 07/15/2004 inSession: The ReAct Trial: Implications in Rheumatoid Arthritis. CME
47 07/15/2004 inSession: Treatment with Adalimumab Halts Radiographic Progression in RA Patients with Moderate Disease. CME
48 07/15/2004 inSession: Future Directions in TNF Antagonist Treatment. CME
49 07/15/2004 inSession: Long-Term Results with Adalimumab Plus Methotrexate in RA. CME

For examples of additional recent inSession reports:

  • Select September 2004 (the default screen).
  • Select Search.
  • In the window on the right side of the screen select any of the four inSession CME programs from EULAR:
09/09/04 inSession: Adding Enfuvirtide to an Optimized Regimen Improves Efficacy for 96 Weeks in Previously Treated HIV Patients
09/09/04 inSession: Response to Enfuvirtide can be Predicted: Implications for Integrating Fusion Inhibition into Antiretroviral Therapy.
09/09/04 inSession: Hard-Gel Formulation of Ritonavir-Boosted Saquinavir plus 2 NRTIs Effective and Safe at 24 Weeks.
9/09/04 inSession: Saquinavir/Ritonavir Plus 2 NRTIs: An Effective Alternative in Reducing Mother-to-Infant HIV Transmission.

 

Hx > Dx > Rx